Monitor insider activity and future hiring trends; no immediate financial impact, but increasing headcount may signal expansion of clinical development efforts.
Price Chart
Executive Summary
Vor Bio granted stock options and RSUs to 8 new employees as inducement awards under its 2023 Inducement Plan. The awards cover 215,700 stock options and 46,235 RSUs, with exercise prices ranging from $7.95 to $24.11 per share, reflecting market closing prices on grant dates.
Key Facts
- Granted stock options for 215,700 shares and RSUs for 46,235 shares to 8 new employees
- Awards made in November 2025 and March 23, 2026 under Nasdaq Listing Rule 5635(c)(4) as material inducements
- Stock options have 10-year term, exercise price equals closing price on grant date ($7.95–$24.11)
- Options and RSUs vest over four years: 25% after 12 months, remainder monthly (options) or quarterly (RSUs)
- No financial performance data, revenue, or clinical updates included
Financial Impact
Minimal near-term financial impact; potential future dilution of ~0.5% based on ~261,935 total shares granted and $500M market cap
Risk Factors
- Future dilution from vesting of options and RSUs
- No performance-based vesting terms disclosed — compensation is time-vested only
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3260855 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | Press Release | $23.37 $23.24 | ▼ −0.58% | ▲ +0.48% | $18.47 (−20.97%) |
Jul 9, 2026 12w ago | 3 | $19.14 $23.67 | ▲ +23.67% | ▲ +21.24% | $18.47 (−3.50%) |
Jun 11, 2026 16w ago | Institutional Cluster | $14.09 $19.75 | ▲ +40.17% | ▲ +38.28% | $18.47 (+31.09%) |
Jun 8, 2026 16w ago | Press Release | $13.29 $20.10 | ▲ +51.24% | ▲ +49.61% | $18.47 (+38.98%) |
May 7, 2026 21w ago | EFFECT | $16.08 $13.44 | ▼ −16.42% | ▼ −19.55% | $18.47 (+14.86%) |
Apr 27, 2026 22w ago | S-3 | $14.38 $14.10 | ▼ −1.95% | ▼ −7.42% | $18.47 (+28.44%) |
Apr 27, 2026 22w ago | DEFA14A | $14.38 $14.10 | ▼ −1.95% | ▼ −7.42% | $18.47 (+28.44%) |
Mar 27, 2026 27w ago | Press Release | $14.48 $14.12 | ▼ −2.49% | ▼ −15.23% | $18.47 (+27.56%) |
Mar 23, 2026 27w ago | Press Release | $12.15 $15.32 | ▲ +26.09% | ▲ +17.19% | $18.47 (+52.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access